Intervention Review

Lycopene for the prevention of prostate cancer

  1. Dragan Ilic1,*,
  2. Kristian M Forbes2,
  3. Craig Hassed3

Editorial Group: Cochrane Prostatic Diseases and Urologic Cancers Group

Published Online: 9 NOV 2011

Assessed as up-to-date: 24 AUG 2011

DOI: 10.1002/14651858.CD008007.pub2

Database Title

Additional Information

How to Cite

Ilic D, Forbes KM, Hassed C. Lycopene for the prevention of prostate cancer. Cochrane Database of Systematic Reviews 2011, Issue 11. Art. No.: CD008007. DOI: 10.1002/14651858.CD008007.pub2.

Author Information

  1. 1

    Monash University, Department of Epidemiology & Preventive Medicine, School of Public Health & Preventive Medicine, Melbourne, Victoria, Australia

  2. 2

    Finnish Forest Research Institute, Suonenjoki, Finland

  3. 3

    School of Primary Health Care, Monash University, Department of General Practice, Notting Hill, Victoria, Australia

*Dragan Ilic, Department of Epidemiology & Preventive Medicine, School of Public Health & Preventive Medicine, Monash University, The Alfred Centre, Level 6, 99 Commercial Rd, Melbourne, Victoria, 3004, Australia. dragan.ilic@med.monash.edu.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 9 NOV 2011

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (298K)Full (327K)

  1. Current Version

    Lycopene for the prevention of prostate cancer

    Dragan Ilic, Kristian M Forbes and Craig Hassed

    Article first published online: 9 NOV 2011 | DOI: 10.1002/14651858.CD008007.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Lycopene for the prevention of prostate cancer

    Kristian M Forbes, Dragan Ilic and Craig Hassed

    Article first published online: 7 OCT 2009 | DOI: 10.1002/14651858.CD008007

View Full Article (HTML) Summary (59K)Standard (298K)Full (327K)